Neural Stem Cell Treatment for Perinatal Brain Injury: A Systematic Review and Meta-Analysis of Preclinical Studies

Abstract

Perinatal brain injury can lead to significant neurological and cognitive deficits and currently no therapies can regenerate the damaged brain. Neural stem cells (NSCs) have the potential to engraft and regenerate damaged brain tissue. The aim of this systematic review was to evaluate the preclinical literature to determine whether NSC administration is more effective than controls in decreasing perinatal brain injury. Controlled interventional studies of NSC therapy using animal models of perinatal brain injury were identified using MEDLINE and Embase. Primary outcomes were brain infarct size, motor, and cognitive function. Data for meta-analysis were synthesized and expressed as standardized mean difference (SMD) with 95% confidence intervals (CI), using a random effects model. We also reported secondary outcomes including NSC survival, migration, differentiation, and effect on neuroinflammation. Eighteen studies met inclusion criteria. NSC administration decreased infarct size (SMD 1.09; CI: 0.44, 1.74, P = .001; I 2 = 74%) improved motor function measured via the impaired forelimb preference test (SMD 2.27; CI: 0.85, 3.69, P = .002; I 2 = 86%) and the rotarod test (SMD 1.88; CI: 0.09, 3.67, P = .04; I 2 = 95%). Additionally, NSCs improved cognitive function measured via the Morris water maze test (SMD of 2.41; CI: 1.16, 3.66, P = .0002; I 2 = 81%). Preclinical evidence suggests that NSC therapy is promising for the treatment of perinatal brain injury. We have identified key knowledge gaps, including the lack of large animal studies and uncertainty regarding the necessity of immunosuppression for NSC transplantation in neonates. These knowledge gaps should be addressed before NSC treatment can effectively progress to clinical trial.

Top 10 Research Themes for Dystonia in Cerebral Palsy

“…5 Exploratory work also suggests that neural precursor cells may be leveraged to augment innate neural repair mechanisms, which could provide potential disease-modifying options for DCP treatment. 17…”

Exploring the neurogenic differentiation of human dental pulp stem cells

“…These stem cells can be either transplanted alone [12] or as part of designed engineered tissue/conduit to replace the defective neuronal tissue [13,14]. Stem cell transplantations have demonstrated positive therapeutic nerve regeneration, functional recovery, and neuronal survival in several neurological traumas such as brain injury [15] and spinal cord injury/transection [16,17], optic nerve crush [18], and injured peripheral nerves [12]. However, the use of stem cells in transplantation therapies may be limited by the small populations differentiated into neuronal cells or undesired cell proliferation or differentiation [19,20].…”

Efficacy and safety of stem cell therapy in cerebral palsy: A systematic review and meta-analysis

“…For example, stem cells have several functions that might be critical to the treatment of CP including immune regulation ( Bennet et al, 2012 ), paracrine effects ( Lv et al, 2021 ), angiogenesis ( Kiasatdolatabadi et al, 2017 ), and neuroplasticity ( Jantzie et al, 2018 ). Collectively, stem cell transplantation is considered a promising therapeutic strategy in clinical practice ( Xie et al, 2020 ), and the effectiveness of stem cell transplantation in the treatment of CP has been preliminarily verified by evidence-based medicine ( Novak et al, 2016 ; Eggenberger et al, 2019 ; Xie et al, 2020 ; Smith et al, 2021 ). However, we found that stem cell treatment protocols were non-uniform across studies, and previous systematic reviews did not provide appropriate recommendations on factors that may affect the therapeutic effect, such as cell type selection, dose and administration.…”